Business Context and Reporting Period
Lunai Bioworks Inc. (LNAI), a Delaware corporation, filed this Form 8-K on October 27, 2025. The report addresses a regulatory notice received from The Nasdaq Stock Market LLC regarding the company's compliance with continued listing standards.
Key Financial Metrics
This filing does not contain standard financial performance data such as revenue, profit, cash flow, or debt levels. The primary metric disclosed is the Market Value of Listed Securities (MVLS).
- Market Value of Listed Securities (MVLS): Below $35 million for the previous 30 consecutive business days.
- Required MVLS Threshold: $35 million (per Nasdaq Listing Rule 5550(b)(2)).
Material Changes
The material change reported is the receipt of a formal notification from Nasdaq indicating non-compliance with the minimum MVLS requirement. This deficiency has persisted for 30 consecutive business days prior to the report date.
Outlook, Risks, and Management Commentary
Compliance Period: The company has been granted 180 calendar days, until April 27, 2026, to regain compliance.
Path to Compliance: To cure the deficiency, the company's MVLS must close at $35 million or more for a minimum of 10 consecutive business days during the compliance period.
Trading Status: The notice is not expected to have an immediate effect on the listing or trading of the company's common stock, which will continue to trade on the Nasdaq Capital Market under the symbol "LNAI."
Delisting Risk: If compliance is not achieved by the deadline, Nasdaq will notify the company that its securities are subject to delisting. The company may appeal this determination to a Nasdaq Hearings Panel, which would stay the delisting pending a decision.
Management Action: The company intends to monitor its MVLS and may consider available options, including potential corporate actions, to regain compliance.
Investor Verification Checklist
- Verify the current Market Value of Listed Securities (MVLS) to assess proximity to the $35 million threshold.
- Monitor the company's stock price performance over the next 10 consecutive business days to track progress toward compliance.
- Review future filings for announcements of corporate actions (e.g., reverse stock splits, capital raises) intended to increase MVLS.
- Confirm the status of the compliance period deadline (April 27, 2026) and any potential appeals if the deadline is missed.